Off the wire
1st LD-Writethru: Chinese shares upward on denial of rumors  • Urgent: Opposition wins Jamaican parliamentary elections -- prelim results  • 1st LD: China's home prices continue upward trend  • Tokyo stocks advance in morning as rising oil prices lift sentiment  • Roundup: Australia to double defence spending over next 15 years  • Obama, Italian PM discuss fighting against Islamic State  • China Exim Bank provides loan for pioneering Ecuadorian university  • Chinese visitors drive surge in New Zealand tourism revenues  • Roundup: BOJ may further ease policy as deflation concerns grow on stagnant CPI data  • Spotlight: G20 ministers, central bankers expected to address global growth concerns  
You are here:   Home

New Zealand reviewing restrictions on medical cannabis

Xinhua, February 26, 2016 Adjust font size:

The New Zealand government is reviewing its guidelines for the approval of medical cannabis use following a series of controversial cases around the narcotic.

Associate Health Minister Peter Dunne said Friday he would also be raising the issue with counterparts in Australia.

Medical cannabis was a new policy area for New Zealand's Ministry of Health and the wider medical profession, so there would inevitably be fine tuning as the process developed, Dunne said in a statement.

The guidelines were set up after a teenager, whose family and doctors had appealed for medical cannabis treatment, died following a severe epileptic seizure last year.

That was so far the only case where ministerial approval had been granted, but former head of the New Zealand Council of Trade Unions Helen Kelly, who is dying of lung cancer, has raised the issue again after doctors applied to use medical cannabis.

"While I am satisfied that on the whole the guidelines are sound, they were prepared as guidance only," said Dunne.

"Nonetheless, some further review would be beneficial and I have asked officials to undertake further consideration of them."

He would also be discussing the issue in Canberra next week at the Australian Drug Foundation's National Drug Summit.

Cannabis-based prescriptions for medicinal use are not available in Australia or New Zealand, which are committed to standardizing regulations as they move to greater economic integration. Endit